Evidence map›Paper›PMID 19555737›Full record

ArticleNeuroscience2009

Temporal changes in mouse brain fatty acid amide hydrolase activity.

S T Glaser, M Kaczocha

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Diurnal Profiles ofFrontiers in neuroscience · 2019
    Article
  2. Article
  3. Review
  4. Article
  5. Does the neuroprotective role of anandamide display diurnal variations?International journal of molecular sciences · 2013
    Article
  6. Article
  7. Article
  8. Article
  9. Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain.The Journal of pharmacology and experimental therapeutics · 2010
    Article
  10. Article
  11. Endocannabinoid signalling: has it got rhythm?British journal of pharmacology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S T GlaserDepartment of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794-5230, USA. sherrye.glaser@stonybrook.edu
M Kaczocha
Stony Brook University · US

Funding

Imaging endocannabinoid degradation in the mouse brainK01DA021806 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI GLASER, SHERRYE T. · 2006 to 2010
$612k
NIDA NIH HHS 1 K01 DA021806-01NIDA NIH HHS K01 DA021806
6 · The paper itself

Abstract

Fatty acid amide hydrolase (FAAH) activity is known to mediate the tone of endogenous fatty acid amides including the endocannabinoid anandamide. FAAH is a potential therapeutic target because genetic or pharmacological ablation of FAAH promotes analgesia and anxiolytic effects without disrupting motor coordination. Little is known about the endogenous temporal fluctuations of brain FAAH activity. This is the first comprehensive study examining temporal fluctuations in mouse brain FAAH activity. Regional mouse brain homogenates were generated at the midpoint of the light ("noon") and dark ("midnight") cycles. While immunoblots revealed no significant changes (P>0.05) in regional activity between these two time points, in vitro activity assays detected a subtle 10% reduction (P<0.05) in cerebellar FAAH activity at midnight. A novel ex vivo autoradiography technique permitted the study of 11 different brain regions, many of which cannot be studied using traditional in vitro methods. The cerebellum and the periaqueductal gray both exhibited significant (P<0.05) reductions in regional FAAH activity in "midnight" brains. These data confirm the need to account for temporal changes in FAAH activity when therapeutically targeting FAAH.

Indexed as

Circadian RhythmAmidohydrolasesAnimalsAutoradiographyBlotting, WesternBrainCerebellumFatty Acid Amide HydrolasesMiceMice, Inbred C57BLPeriaqueductal GrayPeriodicityPhotoperiodTime FactorsAmidohydrolasesFatty Acid Amide Hydrolases

Identifiers

PMID19555737
PMCPMC2773183
OpenAlexW2060502881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.